It was found that p53 expression was elevated when S100A4 expression was enhanced, cyclin D1 was inhibited, and synthesis of the cyclin/CDK complex was blocked suggesting that AML tumor cells are blocked from entering S phase in G1 phase. The gene discussed is TP53; the disease is acute myeloid leukemia.